These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 954840)
21. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs. Sofia RD; Solomon TA; Barry H Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828 [TBL] [Abstract][Full Text] [Related]
22. Delta 9-tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits. Fujimori M; Himwich HE Physiol Behav; 1973 Sep; 11(3):291-5. PubMed ID: 4355439 [No Abstract] [Full Text] [Related]
23. Interaction between delta-9-tetrahydrocannabinol and indomethacin. Green K; Kearse EC; McIntyre OL Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074 [TBL] [Abstract][Full Text] [Related]
24. Combined use of tertiary amine parasympathomimetics with a quaternary amine parasympatholitic--a new perspective to use parasympathomimetic drugs for systemic analgesia. Tekol Y; Eminel S Pharmazie; 2002 Jul; 57(7):485-6. PubMed ID: 12168532 [TBL] [Abstract][Full Text] [Related]
25. Tolerance to delta9-THC in adult rats with differential delta9-THC exposure when immature or during early adulthood. Barnes C; Fried PA Psychopharmacologia; 1974 Jan; 34(3):181-90. PubMed ID: 4819974 [No Abstract] [Full Text] [Related]
26. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat. Taylor DA; Fennessy MR Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330 [TBL] [Abstract][Full Text] [Related]
27. Effects of delta9-tetrahydrocannabinol (THC) on several rodent learning paradigms. Robichaud RC; Hefner MA; Anderson JE; Goldberg ME Pharmacology; 1973; 10(1):1-11. PubMed ID: 4751537 [No Abstract] [Full Text] [Related]
28. Effects of acute administration of delta9-tetrahydrocannabinol on pulmonary hemodynamics of anesthetized dogs. Jandhyala BS; Malloy KP; Buckley JP Eur J Pharmacol; 1976 Jul; 38(1):183-7. PubMed ID: 954827 [TBL] [Abstract][Full Text] [Related]
29. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819 [TBL] [Abstract][Full Text] [Related]
30. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392 [TBL] [Abstract][Full Text] [Related]
31. Effects of delta9-tetrahydrocannabinol and pentobarbital on a cortical response evoked during conditioning. Boyd ES; Boyd EH; Brown LE Psychopharmacology (Berl); 1976 May; 47(1):119-22. PubMed ID: 822438 [TBL] [Abstract][Full Text] [Related]
32. The effects of delta9-tetrahydrocannabinol on action potentials in the mollusc Aplysia. Acosta-Urquidi J; Chase R Can J Physiol Pharmacol; 1975 Oct; 53(5):793-8. PubMed ID: 1201484 [TBL] [Abstract][Full Text] [Related]
33. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Shen M; Thayer SA Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692 [TBL] [Abstract][Full Text] [Related]
34. Divided attention performance of cannabis users and non-users following cannabis and alcohol. Macavoy MG; Marks DF Psychopharmacologia; 1975 Oct; 44(2):147-52. PubMed ID: 1105631 [TBL] [Abstract][Full Text] [Related]
35. Cholinergic modification of naloxone-induced jumping in morphine dependent mice. Brase DA; Tseng LF; Loh HH; Way EL Eur J Pharmacol; 1974 Apr; 26(1):1-8. PubMed ID: 4857603 [No Abstract] [Full Text] [Related]
36. The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat. Hernández-Tristán R; Arévalo C; Canals S; Leret ML J Physiol Biochem; 2000 Mar; 56(1):17-24. PubMed ID: 10879677 [TBL] [Abstract][Full Text] [Related]
37. Catalepsy induced by intrastriatal injections of delta9-THC and 11-OH-delta9-THC in the rat. Gough AL; Olley JE Neuropharmacology; 1978 Feb; 17(2):137-44. PubMed ID: 565018 [No Abstract] [Full Text] [Related]
38. Rabbit behavioral model of marijuana psychoactivity in humans. Consroe P; Fish BS Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517 [TBL] [Abstract][Full Text] [Related]
39. The effects of delta8-THC on the EEG, reticular multiple unit activity and sleep of cats. Wallach MB; Gershon S Eur J Pharmacol; 1973 Nov; 24(2):172-8. PubMed ID: 4358207 [No Abstract] [Full Text] [Related]
40. Mouse-killing and motor activity: effects of chronic delta9-tetrahydrocannabinol and pilocarpine. Miczek KA Psychopharmacology (Berl); 1976 May; 47(1):59-64. PubMed ID: 986662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]